Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23927,85,1.56 [1.06-2.30],0.0239602344664693
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",24428,130,1.37 [0.97-1.94],0.0728967588240784
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",24216,887,1.34 [1.17-1.54],2.568732900465151e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Candidiasis,24454,264,1.05 [0.78-1.42],0.7333053330951931
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23755,2406,1.20 [1.10-1.32],7.129258192225601e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23979,1817,1.23 [1.11-1.36],8.47214571154657e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,24271,862,1.18 [1.01-1.38],0.0314362160251474
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,24382,38,1.09 [0.51-2.33],0.8214637847092296
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,23339,562,1.43 [1.22-1.68],1.1965477318776006e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,22547,530,1.44 [1.22-1.70],1.3192680746140553e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22776,150,1.17 [0.81-1.70],0.4053021982657742
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18182,1060,1.29 [1.13-1.48],0.0001264189840001
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,22572,250,1.66 [1.36-2.04],8.287011281583941e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,24417,1008,1.23 [1.07-1.41],0.0034277946400253
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Mycoses,24512,322,1.10 [0.84-1.43],0.4981894552013797
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23870,541,1.42 [1.20-1.67],4.683367025013367e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,24458,616,1.40 [1.19-1.63],3.337653558829643e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,23541,132,1.33 [0.93-1.90],0.115494124078347
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24553,29,0.52 [0.15-1.87],0.3173750447307122
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other septicaemia,24385,543,1.44 [1.22-1.69],1.205205299332638e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,24410,66,1.31 [0.79-2.17],0.3012805848820296
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other viral diseases,24463,155,1.53 [1.17-2.01],0.0021611381560314
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",24448,140,1.35 [0.98-1.87],0.0699990680836097
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,23633,304,1.33 [1.05-1.68],0.0201312787062923
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,23536,207,1.56 [1.22-2.00],0.0003415391491266
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,23476,67,1.95 [1.40-2.73],9.379884205907752e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24526,46,1.34 [0.72-2.50],0.352301034802237
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24496,114,1.22 [0.81-1.83],0.3355741155010435
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral warts,24420,38,0.59 [0.20-1.71],0.3290314433112882
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],24426,44,1.52 [0.90-2.56],0.1181995213751324
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign lipomatous neoplasm,24295,281,0.83 [0.59-1.18],0.2976961556269563
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24476,67,0.71 [0.33-1.50],0.3639834412694533
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24448,68,0.67 [0.31-1.44],0.2999959461958942
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10956,37,0.94 [0.36-2.41],0.8921022724533364
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",24376,1026,1.13 [0.97-1.31],0.1137438328584463
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm of meninges,24541,44,0.87 [0.38-1.99],0.7479234116236546
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24521,49,1.24 [0.66-2.33],0.5044759595017134
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,24532,78,1.04 [0.59-1.83],0.8867438013204116
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm of ovary,13540,85,0.75 [0.40-1.40],0.3668906547948577
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Ascending colon,24545,241,1.30 [0.99-1.71],0.0618692098187645
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Caecum,24541,180,1.38 [1.03-1.87],0.0334390133664814
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24488,48,1.41 [0.81-2.47],0.2280043534792503
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Descending colon,24547,155,0.92 [0.59-1.42],0.699831178556958
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Rectum,24516,253,1.22 [0.93-1.62],0.1561435969477039
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,24484,473,0.99 [0.78-1.26],0.9657828097727696
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Transverse colon,24545,268,1.10 [0.81-1.49],0.5382175036364074
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Carcinoma in situ of breast,11617,76,0.80 [0.43-1.51],0.4904754146653872
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11656,85,0.83 [0.46-1.49],0.5399200296946287
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",21187,31,1.68 [1.26-2.24],0.0004661718465269
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",21190,34,0.98 [0.40-2.40],0.9667738152318416
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24513,96,0.77 [0.43-1.40],0.399399947193522
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Haemangioma, any site",24513,94,0.77 [0.42-1.41],0.4025940131378911
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Leiomyoma of uterus,12968,358,0.97 [0.75-1.25],0.8261665474353107
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Lung cancer and mesothelioma,18203,157,1.56 [1.17-2.07],0.0021969235206692
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Lymphoid leukaemia,21184,28,2.93 [2.24-3.83],4.6877394921741874e-15
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",21288,132,0.82 [0.50-1.35],0.4389241364168097
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",21233,77,1.38 [0.87-2.19],0.1732953244102908
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11705,70,0.77 [0.39-1.52],0.4500512960934104
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",21201,45,0.91 [0.40-2.05],0.8127190967714686
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",21208,52,1.34 [0.74-2.40],0.3300012304505918
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",21220,64,1.25 [0.71-2.20],0.448572746815388
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11685,50,1.18 [0.66-2.10],0.5734876064861678
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",21207,51,1.37 [0.78-2.40],0.2794599873816549
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9874,353,0.92 [0.68-1.27],0.6254580375790875
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",21242,86,1.20 [0.73-1.97],0.4778772457292229
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",21204,48,1.27 [0.67-2.41],0.4725881468914281
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,21213,57,1.12 [0.60-2.10],0.7111773344282105
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Melanocytic naevi,24343,196,0.98 [0.69-1.41],0.9281122892479938
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Melanocytic naevi of trunk,24509,88,0.79 [0.43-1.46],0.4568249631153301
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Melanoma in situ,21166,40,1.25 [0.64-2.45],0.5118884874250419
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",21211,55,0.95 [0.46-1.95],0.8911097482312093
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",21260,104,1.46 [1.01-2.10],0.0451485337640751
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",21260,104,1.39 [0.94-2.06],0.1001836376086373
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",21216,60,1.48 [0.93-2.36],0.102168924938634
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Other benign neoplasms of skin,24391,133,0.97 [0.62-1.52],0.9045784767171844
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21723,567,1.07 [0.87-1.31],0.5291461138524461
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21753,597,1.08 [0.89-1.32],0.4297834499087648
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,24300,268,1.28 [0.99-1.65],0.0560655939902573
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,23306,41,1.35 [0.71-2.54],0.3600323746126549
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,24099,67,1.11 [0.62-1.99],0.713821023050529
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23839,1961,1.17 [1.05-1.29],0.0028704177333591
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,23523,20,1.69 [0.80-3.55],0.1684390630905746
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,24239,27,0.56 [0.15-2.06],0.3841747530598927
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,24156,891,1.24 [1.07-1.44],0.0034766124896062
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,24156,891,1.24 [1.07-1.44],0.0034766124896062
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,23314,49,1.59 [0.98-2.60],0.0629363794281303
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,24306,803,1.22 [1.05-1.42],0.0106859366075496
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,24308,96,1.34 [0.89-2.01],0.1558107615762139
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,24080,48,1.60 [0.99-2.57],0.0542333345788877
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,24071,39,1.42 [0.77-2.61],0.260784461131485
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,24380,168,1.38 [1.02-1.87],0.0389735709565586
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,24482,61,0.80 [0.38-1.67],0.5522283053271614
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",24356,144,1.36 [0.98-1.89],0.0694419556771662
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,23565,62,0.94 [0.48-1.82],0.8515047145952093
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,21072,180,1.70 [1.35-2.15],6.145414602563433e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22825,107,1.35 [0.90-2.02],0.1460004581581553
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22844,126,1.52 [1.10-2.10],0.0120325673914954
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20924,32,1.42 [0.75-2.69],0.2771239626006764
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22780,64,0.94 [0.49-1.83],0.8603303150877681
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,22476,124,1.00 [0.64-1.57],0.9913049837547128
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",24424,145,1.32 [0.93-1.87],0.1255159338157574
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,24326,47,1.26 [0.68-2.34],0.4599072061887326
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,24310,31,1.06 [0.44-2.59],0.8912889463336385
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,24186,1470,1.11 [0.99-1.26],0.0795339598489505
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21988,1429,1.12 [0.99-1.26],0.0745255667211029
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20931,39,0.96 [0.43-2.18],0.9285710206861784
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",23100,52,0.96 [0.47-1.95],0.9037169830010556
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,21059,167,1.42 [1.06-1.89],0.0170025047285557
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,20948,56,1.36 [0.82-2.26],0.2395673683336638
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,23015,2123,1.02 [0.92-1.14],0.7042494822208625
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,21000,108,1.71 [1.27-2.29],0.0003925914941027
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,21241,349,1.46 [1.20-1.77],0.0001261424941204
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24468,231,1.36 [1.05-1.77],0.0187680569709029
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,24330,93,1.55 [1.09-2.20],0.0154131556485165
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,20983,91,1.43 [0.98-2.10],0.0645631973282569
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20927,35,1.43 [0.76-2.69],0.2684421469634109
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,24177,1129,1.02 [0.89-1.18],0.7400376983302581
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,21003,111,1.67 [1.25-2.24],0.0005628032342923
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,21028,136,1.83 [1.44-2.32],8.641194527237709e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",21242,350,1.04 [0.80-1.36],0.757018723328208
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,20947,55,1.31 [0.75-2.27],0.3390925237290119
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,24324,87,1.61 [1.13-2.28],0.0079913309978806
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,21157,265,1.42 [1.12-1.79],0.0035237382062588
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,21167,275,1.11 [0.84-1.47],0.4518825667012141
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,22404,52,1.00 [0.49-2.03],0.996012097779441
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23930,3038,1.09 [1.00-1.19],0.0533492355357748
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,23073,25,0.62 [0.18-2.15],0.4500011584397501
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,23099,51,1.12 [0.60-2.10],0.7242587223217563
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,24395,1719,0.99 [0.88-1.12],0.898388561758121
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",24398,1716,0.99 [0.88-1.12],0.8925381224101285
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,23079,31,0.92 [0.36-2.34],0.85609976165533
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,24264,1093,1.14 [0.99-1.30],0.0611739320956986
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21685,793,1.39 [1.21-1.59],2.0918273951546585e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24545,109,1.75 [1.31-2.34],0.0001666246619689
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,24309,30,1.19 [0.50-2.83],0.6914228856212252
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,23254,83,0.93 [0.53-1.65],0.8101782266449402
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,23273,102,0.71 [0.39-1.29],0.2557752719735927
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",21005,113,1.37 [0.97-1.94],0.0710571552920262
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22955,108,1.67 [1.20-2.32],0.0022586827841208
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1517,58,1.57 [0.95-2.59],0.0767927178612973
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1614,168,1.48 [1.07-2.05],0.0179018282895878
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22882,35,1.24 [0.58-2.63],0.578520548367388
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1490,31,1.99 [1.13-3.51],0.0168954323617015
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,24188,1341,1.27 [1.13-1.43],5.286470271236789e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,24341,62,1.21 [0.69-2.13],0.5072325797222068
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22602,250,1.16 [0.87-1.54],0.3185295693571435
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,21253,361,1.34 [1.09-1.65],0.0062635308918088
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",24472,152,1.17 [0.81-1.70],0.3959719612508289
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23884,48,1.57 [0.92-2.66],0.0951051982733983
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Angina pectoris,23424,710,1.12 [0.93-1.34],0.2207087444474714
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23929,93,1.06 [0.62-1.80],0.8289384821791258
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23864,28,2.12 [1.29-3.48],0.0029911450192332
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23932,96,1.51 [1.03-2.21],0.0349327567948739
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17428,810,1.11 [0.94-1.31],0.2353978678402281
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,AV-block,22341,161,1.19 [0.83-1.71],0.3421945275747785
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24523,227,1.08 [0.78-1.49],0.64742172201649
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Cardiac arrest,16715,97,1.37 [0.92-2.05],0.1216822860680531
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Cardiomyopathy,22297,117,0.97 [0.59-1.58],0.8929087168776964
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",22255,75,0.95 [0.51-1.75],0.8616161950311164
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24555,15,0.71 [0.15-3.28],0.6591812568843789
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Conduction disorders,22656,476,1.33 [1.10-1.60],0.0036073830928366
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23902,1198,1.16 [1.01-1.33],0.0322293739470266
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22811,5399,1.05 [0.98-1.12],0.1562948424112075
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,DVT of lower extremities,23527,160,1.19 [0.83-1.70],0.3459561531821949
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Endocarditis,22220,40,1.36 [0.73-2.55],0.3333783659373976
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Heart failure, strict",24446,461,1.40 [1.17-1.68],0.0003089002181198
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Hypertension,23319,4393,1.05 [0.98-1.13],0.1936512060869027
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Hypertension, essential",23327,4401,1.05 [0.98-1.14],0.1626585592938629
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Hypertension, portal",24397,48,1.58 [0.97-2.60],0.0688949480309611
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19007,81,1.84 [1.33-2.53],0.0002047747960275
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18968,42,2.48 [1.83-3.35],3.713155228000763e-09
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Hypotension,24463,606,1.24 [1.04-1.48],0.0165150044059462
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,24082,57,0.58 [0.24-1.40],0.2252439702176771
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",24053,1339,1.15 [1.01-1.30],0.0370628009162226
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",24353,276,1.22 [0.93-1.60],0.1534983688989089
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Left bundle-branch block,22365,185,1.30 [0.96-1.77],0.0923974554216535
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,24329,539,1.19 [0.98-1.46],0.0804121515393079
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",23153,439,1.23 [0.99-1.52],0.0600905623775409
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24504,106,1.40 [0.93-2.10],0.1043012485014422
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24540,185,1.33 [0.98-1.81],0.068961014520235
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Oesophageal varices,23398,31,2.09 [1.33-3.29],0.0014016158190302
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other aneurysm,23878,42,0.91 [0.39-2.10],0.8187765499469716
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other arrhythmias,22407,227,1.27 [0.96-1.68],0.0988004970209927
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23896,60,1.76 [1.16-2.66],0.0073605666458543
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23968,132,1.39 [0.98-1.97],0.0625988102650834
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,22293,113,1.08 [0.69-1.69],0.7305196054109924
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other disorders of veins,23430,63,1.41 [0.87-2.29],0.1608230215733599
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,23412,45,1.65 [1.01-2.69],0.0455970649334907
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23862,35,1.51 [0.78-2.94],0.2229440004098623
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,23449,82,0.95 [0.54-1.68],0.8680680924396338
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22704,524,1.29 [1.07-1.55],0.0067986227914336
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23898,41,1.48 [0.84-2.60],0.1751241651298114
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,24143,307,1.40 [1.12-1.75],0.003275534411284
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,24145,139,1.75 [1.34-2.29],4.382024269949108e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",24033,206,1.21 [0.89-1.66],0.2256241608309684
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16831,213,1.21 [0.90-1.63],0.2071649580334568
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23996,182,1.43 [1.07-1.91],0.01472973699995
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),23588,221,1.04 [0.75-1.46],0.8003964016828603
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Pulmonary embolism,24308,302,1.06 [0.79-1.41],0.6961849921552375
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24516,285,1.03 [0.76-1.39],0.8462066741882124
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Right bundle-branch block,22331,151,1.57 [1.17-2.09],0.0022646884664881
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Secondary right heart disease,24142,136,1.75 [1.33-2.30],5.410052203981354e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23931,104,1.56 [1.10-2.21],0.0126496821222252
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",24347,322,1.13 [0.86-1.48],0.3714963987232396
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",24324,355,1.11 [0.86-1.44],0.4241106216270225
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,24062,50,0.72 [0.31-1.69],0.44559610422307
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23886,51,0.76 [0.32-1.79],0.5263499633683375
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Transient ischemic attack,24197,120,1.04 [0.66-1.64],0.8563973825723441
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23951,161,1.00 [0.66-1.51],0.986581878465287
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Varicose veins,23641,274,1.22 [0.94-1.59],0.1393098926352126
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23846,47,0.91 [0.42-1.98],0.8081157431663568
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Venous thromboembolism,24396,468,1.04 [0.82-1.31],0.7602449374174323
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24408,333,1.29 [1.02-1.63],0.0317496527047205
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21860,1256,1.13 [0.99-1.28],0.0634879966172192
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,Any mental disorder,23876,3272,1.09 [1.00-1.18],0.0450683406535285
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",24353,387,1.25 [1.00-1.57],0.0456571835341837
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",22105,1501,1.10 [0.98-1.24],0.1100065954805441
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20682,78,1.38 [0.89-2.13],0.1483983764590489
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,Smoking dependency,24067,1366,1.11 [0.97-1.26],0.1264659959342179
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",22173,1569,1.10 [0.98-1.24],0.1031481845171985
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,Vascular dementia,24454,17,1.47 [0.56-3.86],0.4312924620815787
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Alzheimer disease,24554,65,1.14 [0.64-2.03],0.6564522234201111
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Bell's palsy,23068,66,1.66 [1.12-2.46],0.0107684982813136
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,23432,430,1.08 [0.86-1.36],0.4898771258450286
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Cerebral cysts,24234,181,1.34 [1.00-1.81],0.051910616694573
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24478,199,1.27 [0.93-1.72],0.1291494051695522
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,24421,22,1.02 [0.36-2.90],0.9747361096970314
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,24543,50,1.73 [1.11-2.69],0.0148133819831838
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",24105,52,1.02 [0.50-2.08],0.9499638826784976
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Epilepsy,23169,233,1.38 [1.07-1.78],0.012981072094015
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,24120,1184,1.15 [1.00-1.31],0.046510275632184
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,24527,170,0.89 [0.58-1.36],0.5941835082984894
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Falls/tendency to fall,24104,1474,1.21 [1.08-1.36],0.0007599764098498
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Generalized epilepsy,24221,48,1.36 [0.76-2.45],0.2988067149902061
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Hemiplegia,24426,147,1.46 [1.06-2.00],0.0190281878610606
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Hydrocephalus,24095,42,0.85 [0.36-2.03],0.7169321623563993
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,24532,61,0.70 [0.32-1.56],0.3834110547211616
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,23073,71,0.86 [0.45-1.62],0.6409335136041406
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,23075,73,1.06 [0.60-1.89],0.8365007821756405
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Memory loss,24421,66,1.45 [0.92-2.29],0.1130915178443839
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Migraine,23309,373,1.10 [0.86-1.39],0.4502226001305617
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",24475,337,1.13 [0.88-1.44],0.3268216228929898
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Motor neuron disease,17865,93,1.25 [0.81-1.93],0.3233409791439261
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,24358,131,0.79 [0.48-1.29],0.3432888879992121
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",24015,1013,1.10 [0.94-1.27],0.226084847922868
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Neurological diseases,23262,2703,1.07 [0.97-1.17],0.1696944618906135
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,24466,67,1.49 [0.94-2.36],0.0915068791802741
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",23348,346,1.08 [0.83-1.40],0.5594246559239876
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",24491,202,1.43 [1.09-1.87],0.0100946919420032
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,20491,283,1.02 [0.76-1.37],0.9105490855631136
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,24107,54,1.40 [0.83-2.37],0.2061221291386213
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other disorders of nervous system,24159,106,1.22 [0.79-1.87],0.3669469836624313
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,24431,74,0.93 [0.50-1.73],0.8225097818009756
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other facial nerve disorders,23086,84,1.47 [0.99-2.20],0.0588934628422344
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other headache syndromes,22992,56,0.80 [0.37-1.74],0.5746755293778598
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other neurological diseases,24446,393,1.26 [1.02-1.56],0.0350796565144049
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other sleep disorders,23454,518,1.20 [0.98-1.46],0.0761587986910258
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Parkinson's disease,24541,75,0.68 [0.32-1.43],0.306176003765908
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,24109,56,1.43 [0.90-2.27],0.129674243522138
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Restless leg syndrome,24553,34,1.08 [0.48-2.45],0.8555878598198383
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Sleep apnoea,24334,449,1.19 [0.97-1.47],0.0991463647972174
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Small fibre neuropathy,24320,31,1.61 [0.87-2.97],0.1296253413875441
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,24539,118,1.20 [0.79-1.81],0.394274918996825
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,23030,28,1.55 [0.82-2.91],0.1769906926867078
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24554,66,1.14 [0.64-2.02],0.6622123184423909
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),24442,16,1.53 [0.58-4.02],0.3887832419767333
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,24127,36,0.43 [0.13-1.44],0.1713099973041134
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,24233,189,0.72 [0.46-1.13],0.1576992215539814
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24477,171,1.60 [1.21-2.11],0.0009441272520959
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23883,34,1.51 [0.82-2.75],0.183023902048213
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23917,68,1.00 [0.54-1.86],0.9945048402714344
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",24471,28,0.86 [0.57-1.31],0.4883212559315198
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,24388,57,1.04 [0.53-2.05],0.9004143525938678
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1493,34,1.94 [1.09-3.45],0.0246268707705005
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1769,69,1.49 [0.94-2.35],0.0879807632698139
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,24165,74,0.73 [0.36-1.48],0.3856593236938728
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,24448,554,1.28 [1.07-1.53],0.0079321622619898
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",24271,422,0.93 [0.71-1.20],0.5684445457031739
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23971,122,1.02 [0.65-1.59],0.9404551720815918
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",24471,427,0.72 [0.53-0.97],0.0287729622453217
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24546,50,1.49 [0.89-2.49],0.1262355298375854
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,24401,357,0.71 [0.51-0.98],0.0371551661600639
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",24517,186,0.98 [0.67-1.44],0.930525933292078
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,24496,120,1.01 [0.63-1.61],0.9786833644786328
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23864,15,0.93 [0.60-1.44],0.7545881318373154
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23875,26,0.96 [0.33-2.76],0.9399354921840504
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23878,29,0.76 [0.26-2.27],0.6257124618345616
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24512,344,0.91 [0.68-1.22],0.5347322353615216
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,24253,85,0.91 [0.50-1.65],0.7544853973882727
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,24066,22,0.96 [0.32-2.87],0.9373614248525683
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,24390,59,0.96 [0.48-1.93],0.9055031912450076
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,24460,129,1.01 [0.64-1.59],0.9716013512436849
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,24189,145,0.58 [0.34-1.01],0.0561205799833934
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,24445,69,1.30 [0.79-2.15],0.303091583627355
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,24393,225,0.88 [0.60-1.28],0.4874803732144596
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,24190,99,1.40 [0.95-2.07],0.086692327145359
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23925,958,0.99 [0.83-1.17],0.888378621314573
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,24439,108,1.10 [0.69-1.75],0.680631421141029
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24532,99,1.14 [0.71-1.82],0.583855607749244
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,24081,232,0.92 [0.64-1.31],0.6381032464443998
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,24366,35,1.10 [0.49-2.51],0.8126639530491876
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,24530,34,1.43 [0.75-2.75],0.2770719195555142
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23885,36,1.74 [1.06-2.86],0.0271754409512156
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23950,101,0.74 [0.41-1.35],0.3313729743028146
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23952,58,0.92 [0.45-1.91],0.832227058497946
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,24095,51,0.63 [0.26-1.54],0.3075950619211882
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23942,48,1.20 [0.62-2.30],0.5879395666172389
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,24216,48,0.97 [0.47-2.02],0.940918234947574
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",24249,81,1.02 [0.57-1.81],0.9585465335105045
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23925,76,0.99 [0.54-1.81],0.97462112146542
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,24001,107,1.36 [0.93-2.00],0.116562853364627
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23925,31,1.52 [0.77-2.98],0.2260460700642325
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23701,734,0.94 [0.78-1.15],0.5702115902151375
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23894,45,0.86 [0.38-1.96],0.714355928483591
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,24361,270,1.05 [0.78-1.42],0.7536863633398583
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,24123,32,0.75 [0.25-2.26],0.6143975699197923
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),24203,112,1.44 [1.00-2.05],0.0482173681406759
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,24370,56,0.90 [0.43-1.86],0.7666323430191067
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,24513,82,1.39 [0.91-2.11],0.1286977150463747
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,24444,128,1.10 [0.72-1.66],0.6624747916558906
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,24365,51,1.46 [0.87-2.47],0.1548127205919127
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,24366,52,1.00 [0.50-2.00],0.9941063450878924
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,24470,480,1.21 [0.99-1.48],0.068778657292494
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,24288,298,1.31 [1.03-1.67],0.0287228641571189
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,24077,87,1.39 [0.90-2.15],0.1346158719244512
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,24059,69,0.79 [0.39-1.60],0.5061056586565942
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Acute pharyngitis,24291,69,1.29 [0.79-2.12],0.3060388836526083
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,24435,213,1.37 [1.05-1.78],0.0205448984419017
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,24280,58,1.49 [0.94-2.37],0.0934029958775709
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,All influenza,23402,69,1.39 [0.87-2.23],0.1734182484709123
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),23401,68,1.43 [0.90-2.27],0.1344421246264394
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Allergic asthma (mode),18167,121,0.74 [0.42-1.28],0.2805705635888209
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Allergic rhinitis,24426,280,0.82 [0.58-1.16],0.2583760645031559
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",19486,1574,1.14 [1.02-1.28],0.0243595201308504
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19589,1543,1.17 [1.04-1.31],0.0069255760841191
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),24303,85,2.01 [1.51-2.67],1.932420092930056e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",23383,50,1.94 [1.31-2.88],0.0008932910901199
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Bronchiectasis,21831,159,1.43 [1.05-1.93],0.021100617732558
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21706,34,0.91 [0.36-2.29],0.8387806213909659
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23772,2100,1.17 [1.06-1.29],0.0015465627087291
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",23236,60,0.95 [0.47-1.89],0.8752122507575609
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Chronic sinusitis,23322,146,1.18 [0.81-1.71],0.3888841736658576
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",24464,645,1.47 [1.27-1.70],3.677770140656145e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Deviated nasal septum,23298,122,1.13 [0.73-1.74],0.5746254323605018
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22828,3787,1.17 [1.09-1.26],2.881384143903972e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23521,345,1.00 [0.76-1.32],0.9745111582830228
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Early onset COPD,24280,461,1.53 [1.30-1.81],5.427282909106212e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Emphysema,21840,168,1.56 [1.18-2.05],0.0017417958341234
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,23401,102,1.61 [1.16-2.24],0.0048615025670465
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Influenza and pneumonia,24392,1059,1.34 [1.19-1.52],3.9430273986484e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Interstitial lung disease,23422,123,1.59 [1.17-2.15],0.0029620946919435
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Later onset COPD,23251,184,1.32 [0.97-1.80],0.0736986440531358
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24547,137,1.45 [1.05-2.01],0.0238721524138255
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Nasal polyp,23278,102,1.17 [0.74-1.85],0.4962521263738766
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,24359,566,1.32 [1.11-1.57],0.001391039473488
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other diseases of pleura,24390,1116,1.34 [1.19-1.52],2.10278402181819e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23973,797,1.06 [0.89-1.26],0.4919556468311272
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other pleural conditions,23307,33,1.91 [1.18-3.10],0.0089125825238097
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24500,181,1.65 [1.30-2.11],4.690813271637309e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24479,760,1.31 [1.13-1.53],0.0003701443326478
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pleural effusion,23810,536,1.39 [1.17-1.65],0.000148055156254
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pleural plaque,23323,49,2.12 [1.46-3.10],9.358620602895916e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",24204,871,1.31 [1.13-1.51],0.0002298597583651
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24530,120,1.47 [1.04-2.08],0.0270733526459102
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pneumothorax,23331,57,1.11 [0.59-2.08],0.7560250403573918
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pollen allergy,24525,241,0.75 [0.51-1.11],0.1468231997948882
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pulmonary oedema,24355,36,1.75 [1.06-2.91],0.0292487720334801
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Respiratory insufficiency,18079,33,1.50 [0.81-2.78],0.1946508252421931
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,24339,546,1.33 [1.12-1.59],0.0010183297599579
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,23456,280,0.83 [0.59-1.16],0.276037667560235
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Viral pneumonia,23498,165,1.37 [1.00-1.88],0.0520498477448333
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",24317,142,1.34 [0.95-1.90],0.0956542763737206
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,14143,87,1.23 [0.78-1.93],0.3753400742380701
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18804,58,0.92 [0.45-1.88],0.819841154912212
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Acute appendicitis,24374,136,0.90 [0.57-1.44],0.6669216977675225
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Acute gastritis,19625,62,0.74 [0.34-1.59],0.4366134458041032
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Acute pancreatitis,23119,153,0.77 [0.48-1.24],0.2823430924766157
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Acute peritonitis,24151,61,1.68 [1.12-2.51],0.0113223405345848
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23868,77,1.63 [1.11-2.39],0.012752382781852
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Barrett oesophagus,19882,319,1.23 [0.96-1.57],0.1030366785686289
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",23015,49,0.99 [0.47-2.08],0.9878608243870884
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",24191,49,1.00 [0.47-2.10],0.9945098532872888
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Cholecystitis,23122,156,1.12 [0.77-1.63],0.5572482873860283
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Cholelithiasis,23805,839,0.89 [0.74-1.07],0.2325569445980841
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Chronic gastritis,19787,224,1.07 [0.77-1.47],0.6988972059028555
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Chronic pancreatitis,23002,36,1.31 [0.65-2.62],0.4491495919618476
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",24424,75,1.78 [1.25-2.53],0.0014815338085616
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Coeliac disease,23276,98,1.31 [0.87-1.98],0.1928643780385856
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Collagenous colitis,23156,48,0.71 [0.29-1.71],0.4430392843587115
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,24382,183,0.91 [0.61-1.36],0.6412064326811766
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Constipation,24357,1027,1.18 [1.03-1.36],0.0200769182425235
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Crohn disease,23191,83,1.02 [0.59-1.76],0.9533162843565997
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",24242,55,1.00 [0.51-1.99],0.991381986980266
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Crohn's disease NAS,23186,78,0.76 [0.39-1.48],0.4237372401049274
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Dental caries,23811,233,0.98 [0.70-1.37],0.9012844616473156
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22684,1614,1.07 [0.95-1.20],0.279111382261601
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of appendix,24412,174,0.91 [0.61-1.36],0.6440584045521859
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of liver,24446,655,1.25 [1.06-1.48],0.0081350537967972
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22998,3435,1.06 [0.98-1.16],0.1394950913138552
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",24118,540,1.06 [0.86-1.30],0.5912832408610296
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of peritoneum,24476,386,1.17 [0.93-1.46],0.1842727194605828
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23693,115,0.92 [0.56-1.52],0.7556796231420942
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23553,61,0.73 [0.33-1.59],0.4290904100439909
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of the digestive system,24302,1124,1.23 [1.08-1.40],0.0021479366078902
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of tongue,23559,107,1.19 [0.78-1.83],0.4197107502607837
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",24096,1130,0.91 [0.77-1.06],0.2254965528486775
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20908,2162,1.03 [0.93-1.15],0.5503387470668527
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Duodenal ulcer,19696,133,1.19 [0.80-1.77],0.3939657465113231
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24488,102,1.10 [0.68-1.79],0.6878494028104856
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24434,72,1.33 [0.84-2.11],0.2266260016624446
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23884,93,1.61 [1.13-2.29],0.0085572220914433
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18904,158,0.87 [0.56-1.36],0.5398441226944892
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Functional dyspepsia,20021,458,0.99 [0.79-1.26],0.964065127170004
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gastric ulcer,19818,255,0.87 [0.61-1.23],0.41544611035911
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21567,2004,1.05 [0.94-1.17],0.409322797336449
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19934,371,0.97 [0.75-1.27],0.8510114626656113
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19993,7130,1.08 [1.02-1.14],0.0122576045156843
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,GI-bleeding,24080,902,1.24 [1.07-1.43],0.0039737268838393
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23639,61,1.46 [0.93-2.30],0.0992295088011658
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,19542,1123,1.02 [0.88-1.19],0.7717132865554995
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23836,45,1.57 [0.93-2.66],0.092193543338567
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Hernia,23502,2432,1.02 [0.92-1.13],0.7516855278574047
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Impacted teeth,24444,68,1.30 [0.80-2.11],0.2935038221576671
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Impaction of intestines,18778,32,1.18 [0.54-2.54],0.6787340656870794
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Inguinal hernia,21676,606,0.97 [0.77-1.21],0.7677218624488573
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",21141,71,0.85 [0.42-1.75],0.6674313546464715
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18811,65,1.01 [0.54-1.91],0.9677844192427968
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Intestinal malabsorption,23296,118,1.22 [0.82-1.82],0.3231405268122692
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,19260,514,1.04 [0.84-1.28],0.7338110327356566
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24529,340,1.35 [1.09-1.68],0.0064407963689454
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23733,625,1.18 [0.98-1.41],0.0740805185072567
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23894,786,1.10 [0.93-1.30],0.2628489064679052
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19694,131,1.36 [0.96-1.95],0.086641855119141
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Oesophagitis,20000,437,1.12 [0.89-1.40],0.3418791396880057
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24515,120,1.32 [0.92-1.90],0.1376972541624884
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,21114,44,0.47 [0.16-1.36],0.1637844629698547
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19901,1155,1.11 [0.96-1.27],0.1465425916380278
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,23141,175,1.11 [0.78-1.58],0.5628134686601136
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,23107,141,0.71 [0.43-1.18],0.1863973072910039
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of intestine,20096,1350,1.06 [0.93-1.21],0.3710758155827444
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of intestines,23086,4340,1.08 [1.00-1.16],0.036744919005571
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23558,174,1.13 [0.80-1.60],0.4882291966000729
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of liver,24318,527,1.24 [1.03-1.50],0.0237327953908298
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20047,484,1.13 [0.91-1.40],0.2578209619368218
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of pancreas,23042,76,1.07 [0.61-1.87],0.8105759550587138
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,24428,338,1.05 [0.80-1.36],0.7318094706192482
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,20244,681,1.21 [1.02-1.42],0.0263563143628395
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,24094,916,1.23 [1.07-1.42],0.0048777973139712
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23730,152,0.93 [0.60-1.43],0.7325596667549185
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19818,1072,1.17 [1.02-1.34],0.0233095259476856
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21135,1572,1.13 [1.00-1.27],0.0443150658026452
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23863,72,1.37 [0.88-2.16],0.1667554186028779
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23791,683,1.14 [0.96-1.36],0.1346585555200107
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18960,214,1.21 [0.89-1.63],0.2200394065013914
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24418,84,1.24 [0.79-1.96],0.3547565545487607
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19062,316,1.19 [0.93-1.53],0.1631719886599729
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",23303,125,1.12 [0.73-1.71],0.6046172171498718
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Recurring oral aphthae,24546,55,1.35 [0.79-2.30],0.2764919256267569
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23591,116,1.22 [0.81-1.83],0.3425450700874933
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Toxic colitis,23131,23,1.18 [0.46-3.03],0.7295937182502911
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19737,174,1.30 [0.95-1.79],0.1036251976872877
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Ulcerative colitis,23243,135,1.16 [0.78-1.71],0.4581558041275811
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",23225,117,1.17 [0.77-1.78],0.4710086168431627
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Umbilical hernia,21315,245,0.68 [0.46-1.02],0.0631755804067362
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18843,97,0.75 [0.41-1.38],0.3584725623629157
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Ventral hernia,21278,208,1.29 [0.97-1.71],0.0823555524027619
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Volvulus,18805,59,1.07 [0.57-2.00],0.8399498787082788
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,24512,138,0.96 [0.61-1.50],0.8405042744048092
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,24314,75,1.50 [0.99-2.27],0.0579551712298949
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,23238,135,1.31 [0.94-1.83],0.1142122440095986
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23977,491,1.15 [0.93-1.42],0.1875773056516468
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23671,185,1.25 [0.91-1.73],0.1681079786968399
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,23254,151,1.09 [0.74-1.61],0.6564378975707212
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,24323,210,1.04 [0.74-1.46],0.8190688865613416
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,24465,352,1.13 [0.89-1.45],0.3143882008399726
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,24153,40,1.36 [0.74-2.50],0.3221800979245041
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,23251,2297,1.05 [0.95-1.16],0.3480623020530488
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,24141,384,1.02 [0.79-1.31],0.9033829280082276
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,24027,270,0.93 [0.67-1.28],0.640053730942166
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,24196,710,1.17 [0.98-1.39],0.079484712852166
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",24542,41,1.13 [0.55-2.33],0.7301709321740385
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,23158,55,1.02 [0.52-1.97],0.9627539551389392
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23795,38,1.62 [0.97-2.71],0.064993238376289
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,24317,204,1.05 [0.74-1.48],0.7892115767571851
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,23367,264,0.97 [0.70-1.33],0.8269122797319077
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,23137,34,1.37 [0.70-2.69],0.3638218000618826
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,24478,66,1.33 [0.81-2.20],0.2586393259331651
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23607,121,0.93 [0.57-1.53],0.7861849024390855
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,24376,137,1.07 [0.71-1.62],0.7481032393806593
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,24138,25,1.88 [1.14-3.09],0.0137197104792302
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,23151,48,0.79 [0.34-1.82],0.5811977375748434
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,24099,996,1.10 [0.95-1.28],0.2060309683245874
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",23397,294,0.97 [0.72-1.31],0.850815470980173
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,23140,37,1.31 [0.67-2.57],0.4374124581973779
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24479,240,1.13 [0.84-1.52],0.4246396052385994
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,24167,54,1.11 [0.59-2.11],0.7484609534201805
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,24436,197,1.09 [0.78-1.53],0.6214241972912962
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24527,153,0.85 [0.54-1.34],0.4836074238944521
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,23216,113,1.26 [0.86-1.84],0.2302182422463025
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,23277,174,0.97 [0.65-1.44],0.8893368497533635
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24521,147,0.88 [0.56-1.39],0.5856840873715345
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",23219,116,1.56 [1.13-2.14],0.0064390031024086
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,24522,110,1.04 [0.65-1.67],0.8681899077620934
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,21517,120,1.15 [0.76-1.75],0.5073939835710013
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22898,4155,1.07 [0.99-1.15],0.0834653648395573
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21698,2955,1.08 [0.99-1.18],0.087362749189146
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,21482,85,1.58 [1.10-2.27],0.0126173662116641
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,22012,136,0.89 [0.56-1.43],0.6273229735393384
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,22020,144,1.42 [1.04-1.93],0.0259942262622851
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,24344,108,0.68 [0.37-1.24],0.2074840992767429
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21919,43,1.07 [0.51-2.26],0.8567497279431354
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19417,674,1.04 [0.86-1.26],0.6496993690643411
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24498,114,1.41 [0.98-2.03],0.0619936134764428
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,22135,259,1.26 [0.97-1.63],0.0779491179331509
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21446,5568,1.07 [1.00-1.14],0.0433033302716094
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,23293,101,1.31 [0.87-1.98],0.2016391111961885
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,21507,110,1.28 [0.85-1.93],0.2310323767919355
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21952,555,1.07 [0.87-1.31],0.5432204868941827
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23754,1878,1.15 [1.03-1.28],0.0103804568097814
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21601,204,1.34 [1.00-1.79],0.0504768595666476
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21660,263,1.17 [0.90-1.54],0.2460443291804757
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,21535,138,0.79 [0.48-1.29],0.3422311853160933
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,24071,35,0.67 [0.23-1.93],0.4602867305722826
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19911,1168,1.06 [0.92-1.22],0.4453922267288847
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,19087,344,1.26 [1.00-1.58],0.0538816687830246
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24504,334,1.30 [1.02-1.65],0.0328093053560073
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18809,66,0.77 [0.38-1.58],0.474438561872728
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19057,314,1.05 [0.81-1.37],0.7055856735852664
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21691,294,1.15 [0.87-1.50],0.3241894656278861
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19426,683,0.96 [0.79-1.18],0.7203577262161912
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21901,25,1.15 [0.47-2.84],0.7548231349035341
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,22376,500,1.24 [1.03-1.50],0.0266130120361251
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,22132,256,1.12 [0.84-1.50],0.4498513358687843
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19375,632,0.89 [0.72-1.11],0.3101249348684026
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,21468,71,1.21 [0.72-2.04],0.4784004907727716
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",21451,54,1.50 [0.93-2.41],0.0974468565459855
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,23246,54,1.20 [0.65-2.25],0.5576309038804145
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,24255,1063,1.21 [1.06-1.39],0.0044223823259571
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23795,603,1.27 [1.07-1.50],0.0063240216560884
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",24446,308,1.34 [1.07-1.68],0.0103422009103898
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,20351,1608,1.18 [1.05-1.31],0.0044421376427731
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18810,67,1.36 [0.84-2.19],0.2130355629310936
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,21468,71,1.30 [0.80-2.12],0.2915470158598064
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18769,26,1.37 [0.64-2.93],0.4145093703791485
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18845,102,1.26 [0.84-1.89],0.2712151311916685
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,23408,216,0.84 [0.57-1.23],0.377234871788477
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,23416,224,1.30 [0.99-1.70],0.05453054744655
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,24518,77,1.26 [0.77-2.04],0.3566376021289495
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",23275,1399,1.19 [1.06-1.34],0.0033361175826661
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,21506,109,0.88 [0.52-1.50],0.6481392991004805
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18856,113,0.89 [0.54-1.48],0.6614246047039855
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,22445,569,1.14 [0.94-1.39],0.1736472298219379
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20575,1832,1.09 [0.98-1.22],0.1141674249559851
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,24089,53,0.97 [0.49-1.95],0.9403592901639916
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,24529,71,1.53 [1.00-2.32],0.0481751136358247
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,21466,69,1.18 [0.68-2.05],0.5490525956739041
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",22388,991,1.19 [1.04-1.38],0.013029948622876
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,21460,63,1.07 [0.58-1.98],0.8310902267754151
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19753,1010,1.11 [0.96-1.29],0.1694306824288209
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,23290,98,0.68 [0.36-1.28],0.2288114305173666
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,21456,59,1.26 [0.73-2.19],0.4087167973067456
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21980,104,1.14 [0.73-1.79],0.5699608282182331
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21753,356,1.38 [1.12-1.70],0.0025524151005848
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,24227,191,1.40 [1.07-1.84],0.0135959935640626
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,22303,427,1.31 [1.08-1.60],0.0070364877641356
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,24455,293,1.29 [1.01-1.64],0.0377975284307737
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,24538,34,0.70 [0.24-1.99],0.5002208926845062
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21586,189,1.20 [0.87-1.67],0.2663342611000441
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19676,550,1.21 [1.00-1.46],0.0451049049754801
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21847,450,1.14 [0.92-1.42],0.241900906796451
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21548,151,1.55 [1.14-2.10],0.0049736938757633
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18778,35,1.48 [0.81-2.69],0.2018132438962566
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,20328,1585,1.13 [1.00-1.27],0.0439791794370018
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19147,404,0.98 [0.76-1.26],0.8642901536442997
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,24114,78,1.47 [0.97-2.24],0.0709911115995697
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",24486,45,1.50 [0.88-2.55],0.1375692194058647
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",23116,26,0.47 [0.12-1.85],0.2808948688257643
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18816,73,1.52 [1.01-2.29],0.0463756735516765
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21960,84,1.13 [0.68-1.87],0.63021016297542
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19055,312,1.36 [1.09-1.69],0.0066298518006041
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21641,244,1.13 [0.83-1.53],0.4349907997382912
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,22072,196,1.59 [1.25-2.01],0.0001217360108147
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21971,95,1.55 [1.11-2.17],0.0095225143015398
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20751,41,1.35 [0.76-2.41],0.304898006122799
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24541,37,0.77 [0.30-2.02],0.600949741699099
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21935,538,1.18 [0.97-1.43],0.0963649260856645
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],24115,79,1.37 [0.91-2.08],0.1337912762339657
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,23581,2184,1.13 [1.03-1.25],0.0124583774290036
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",21498,101,1.31 [0.87-1.98],0.1879974111311298
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,22204,328,1.17 [0.91-1.50],0.2304084624564279
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,23280,170,1.02 [0.70-1.49],0.9204013633429986
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,22012,136,1.05 [0.70-1.60],0.8011111357303714
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22839,963,1.06 [0.90-1.24],0.5028875082565682
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,22506,630,1.08 [0.89-1.30],0.4499709008807402
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],21437,40,1.02 [0.46-2.28],0.9555360235449438
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,24181,145,1.40 [1.04-1.89],0.0286540667039
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,21537,140,0.92 [0.58-1.44],0.7036818717876179
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,21451,54,1.80 [1.24-2.63],0.0021701565063344
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18777,34,1.23 [0.57-2.65],0.6051062002147616
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Acute renal failure,24089,753,1.41 [1.22-1.63],2.210619480574841e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9964,65,0.89 [0.47-1.66],0.7054941749266734
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,13257,72,0.91 [0.50-1.67],0.7688284571022448
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,24292,276,1.03 [0.75-1.39],0.872565012246347
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,24071,55,0.72 [0.31-1.67],0.4485676088927006
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23902,566,1.65 [1.44-1.90],2.104058382563876e-12
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,24390,18,2.45 [1.53-3.93],0.0002045416782382
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,24402,162,1.03 [0.69-1.53],0.8979147708692864
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Cystitis,22552,138,1.43 [1.04-1.97],0.0281358545699054
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Dialysis,23379,43,2.46 [1.83-3.30],2.0127535817950336e-09
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10620,1009,1.01 [0.85-1.20],0.9128330533146518
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13363,178,1.08 [0.77-1.52],0.6450087165663831
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Endometriosis,10016,117,1.28 [0.92-1.77],0.1372303768163992
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10239,340,0.81 [0.60-1.09],0.1635448975971341
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10284,385,1.01 [0.79-1.29],0.966978873392376
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20705,3780,1.13 [1.05-1.22],0.0017767231045891
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,24431,59,1.56 [0.99-2.44],0.0532436132102067
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Hydrocele,9683,72,1.34 [0.80-2.25],0.2692934754336808
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,23252,193,1.30 [0.96-1.76],0.087760209333906
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10284,673,1.05 [0.85-1.29],0.6567225757177579
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,13245,214,1.21 [0.92-1.60],0.1802677295229685
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9704,93,1.01 [0.58-1.78],0.9600889459439694
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Irregular menses,13251,110,0.86 [0.52-1.41],0.5531402617108838
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Menorrhagia,10164,265,0.82 [0.59-1.14],0.2344121394230634
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,22472,58,1.51 [0.94-2.43],0.0868767527883889
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,11153,1254,1.11 [0.98-1.26],0.0894941821127104
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9658,47,1.20 [0.59-2.44],0.6177393781900489
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9984,85,0.83 [0.47-1.47],0.5206898441639686
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",24544,36,1.98 [1.28-3.08],0.0023301504164535
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24549,42,1.36 [0.76-2.43],0.2999062210335711
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23777,1363,1.26 [1.12-1.42],7.935101185549392e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22840,426,1.31 [1.06-1.61],0.0110049905695093
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,13241,56,0.70 [0.32-1.55],0.3845151131651856
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24507,267,1.28 [0.98-1.67],0.0665441537132992
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9753,142,0.89 [0.55-1.46],0.6441367161139
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9716,105,1.23 [0.77-1.94],0.3853939597277185
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9678,67,0.59 [0.26-1.36],0.2184798543351202
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,24520,48,1.61 [1.02-2.54],0.0399281087001483
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,23416,1002,1.27 [1.11-1.45],0.0003915219254845
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,13140,109,1.23 [0.83-1.80],0.2987635646924028
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9972,73,0.98 [0.55-1.74],0.9352110833432908
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",10106,207,0.87 [0.60-1.26],0.4695867072332983
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9952,53,1.57 [1.04-2.37],0.0325798290557757
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9994,95,1.11 [0.70-1.76],0.6483508033529408
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,23284,225,1.35 [1.03-1.76],0.0281414599087166
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,24332,92,1.21 [0.75-1.93],0.43782855481493
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,10061,162,1.04 [0.72-1.49],0.8473480712133049
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9969,70,0.66 [0.32-1.35],0.2543794500901793
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10274,375,0.95 [0.73-1.23],0.6770505446387844
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9958,59,1.62 [1.10-2.38],0.0151870804320932
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,10231,332,1.23 [0.99-1.53],0.0638457043056177
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,24413,41,1.82 [1.14-2.90],0.0120253552891214
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9708,97,1.48 [1.01-2.19],0.0456980282893544
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24392,1333,1.34 [1.20-1.50],3.378519077693481e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",23184,125,1.12 [0.75-1.68],0.5868395817336587
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,23396,60,1.83 [1.27-2.63],0.0012425354943702
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,24076,60,0.69 [0.30-1.55],0.3644376654735849
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Urethral stricture,22567,153,0.93 [0.60-1.45],0.7526571473788843
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Urolithiasis,24349,333,0.92 [0.68-1.24],0.5853631753103006
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9985,86,1.00 [0.60-1.69],0.991365498514656
